Condition
Prolapse Pelvic
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07413861Not ApplicableNot Yet RecruitingPrimary
Vaginal Natural Orifice Transluminal Endoscopic (vNOTE) Hysterectomy With Uterosacral Suspension
NCT06430931Not ApplicableRecruiting
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery
NCT07213635Phase 4Recruiting
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
NCT04560543Not ApplicableRecruitingPrimary
Prophylactic Laparoscopic Suspension After McCall
Showing all 4 trials